StartUp Health July 23, 2024
Nicole Kinsey

This week’s health innovation funding highlights advancements in AI-powered solutions, improving patient access to care, expanding at-home healthcare options, enhancing patient engagement and privacy, and more.

This week’s reported health innovation funding included:

CytoReason, a Tel Aviv, Israel-based developer of computational disease models for predictive insights, raised $80M from OurCrowd, NVIDIA, Pfizer, and Thermo Fisher Scientific. source>

Truvian Health, a San Diego, CA-based provider of a blood testing platform, raised $74M led by Wittington Ventures and Great Point Ventures, with participation from DNS Capital, Medical Excellence Capital, Tao Capital, TYH Capital, and 7wireVentures. source>

Brenig Therapeutics, a Dover, DE-based neurology-focused drug development company utilizing an AI/ML-based discovery platform, raised $65M led by NEA, with participation from OrbiMed, Torrey Pines Investments....

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), Digital Health, Investments, Technology, Trends
Related Articles:
Thoma Bravo Becomes Giant Tech Investor, Steers Clear of Blockchain
Monster VC deals: $1B+ AI rounds keep coming as investors hedge their bets on who the next tech giant will be
AI Startups SSI, You.com Secure Funding; HP Reports Strong AI Sales
California passes bill targeting PE healthcare investments
24 Steps to Launch a Start-Up

Share This Article